Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Eutropin Formulations in Healthy Males
NCT03154840Phase 1Unknown
- Sponsor
- LG Chem
- Start
- May 2017
- Primary completion
- Jul 2017
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Eutropin in growth hormone deficiency (GHD) (3 arms), sponsored by LG Chem. Primary endpoint: Area Under the Curve to the Last Measurable Concentration at Week 3. Status: unknown.
02
Drugs
Eutropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT03154840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03154840.